tradingkey.logo
tradingkey.logo
Search

Ensysce Biosciences Inc

ENSC
Add to Watchlist
0.260USD
+0.003+0.97%
Close 07-31 16:00ETQuotes delayed by 15 min
2.41MMarket Cap
LossP/E TTM

ENSC Financials

See Ensysce Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Ensysce Biosciences Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.52/-0.73
Revenue / Forecast
961.00K/1.90M
Period
FY2025 Earnings
Revenue(YoY)
5.07M
-2.75%
EPS(YoY)
-3.98
65.24%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
62.55%-0.52
74.27%-0.74
-228.74%-1.29
76.49%-0.79
83.09%-1.39
85.61%-2.89
107.68%1.00
77.30%-3.35
73.73%-8.21
92.66%-20.06
---13.07
---14.75
---31.25
---273.21
----
----
----
----
----
----
Revenue
-27.18%961.00K
44.39%1.88M
-85.58%493.10K
654.38%1.37M
331.69%1.32M
153.12%1.30M
685.26%3.42M
-62.93%181.80K
-61.28%305.72K
-64.07%515.03K
55.85%435.38K
136.41%490.47K
30.93%789.63K
-12.34%1.43M
-76.74%279.35K
-53.33%207.47K
--603.10K
--1.64M
--1.20M
--444.52K
Net Profit
-82.80%-3.56M
22.35%-2.77M
-663.51%-3.73M
11.91%-1.73M
37.58%-1.95M
-1.72%-3.56M
124.61%661.77K
11.99%-1.97M
-41.92%-3.12M
36.54%-3.50M
72.83%-2.69M
72.05%-2.24M
-31.77%-2.20M
49.06%-5.52M
42.33%-9.90M
-755.04%-8.00M
2.62%-1.67M
-691.85%-10.84M
-7943.57%-17.16M
-135.84%-935.54K
Net Margin
-151.04%-370.07%
46.22%-147.05%
-4006.99%-756.26%
88.32%-126.40%
85.54%-147.42%
59.82%-273.42%
103.13%19.36%
-137.08%-1082.41%
-267.26%-1019.41%
-78.05%-680.42%
---618.04%
---456.56%
---277.57%
---382.16%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
103.21%11.34%
-23.64%4.12%
195.57%12.19%
-53.15%7.62%
15.13%5.58%
-82.92%5.39%
-62.16%4.13%
131.87%16.26%
--4.85%
-57.85%31.56%
--10.90%
--7.01%
--0.00%
--74.88%
----
----
----
----
----
----
Revenue
-27.18%961.00K
44.39%1.88M
-85.58%493.10K
654.38%1.37M
331.69%1.32M
153.12%1.30M
685.26%3.42M
-62.93%181.80K
-61.28%305.72K
-64.07%515.03K
55.85%435.38K
136.41%490.47K
30.93%789.63K
-12.34%1.43M
-76.74%279.35K
-53.33%207.47K
--603.10K
--1.64M
--1.20M
--444.52K
Operating profit
-81.05%-3.56M
22.22%-2.78M
-680.24%-3.74M
10.48%-1.75M
-6.76%-1.97M
-13.33%-3.58M
123.81%644.75K
14.76%-1.96M
28.04%-1.84M
49.11%-3.16M
56.07%-2.71M
67.49%-2.29M
46.67%-2.56M
-209.00%-6.20M
63.50%-6.16M
-1609.86%-7.06M
-1544.64%-4.80M
-2018.34%-2.01M
-5778.70%-16.89M
-112.79%-412.62K
Net Profit
-82.80%-3.56M
22.35%-2.77M
-663.51%-3.73M
11.91%-1.73M
37.58%-1.95M
-1.72%-3.56M
124.61%661.77K
11.99%-1.97M
-41.92%-3.12M
36.54%-3.50M
72.83%-2.69M
72.05%-2.24M
-31.77%-2.20M
49.06%-5.52M
42.33%-9.90M
-755.04%-8.00M
2.62%-1.67M
-691.85%-10.84M
-7943.57%-17.16M
-135.84%-935.54K
Current assets
-54.36%2.01M
35.51%7.24M
-67.79%2.93M
114.72%5.28M
-6.29%4.40M
133.51%5.34M
229.63%9.09M
-57.99%2.46M
39.34%4.70M
-56.81%2.29M
-64.01%2.76M
-18.62%5.86M
-71.09%3.37M
-66.17%5.30M
-14.11%7.66M
-13.92%7.19M
5008.56%11.66M
6816.15%15.66M
8662.10%8.92M
4385.55%8.36M
Total current liabilities
61.08%2.84M
106.95%4.57M
-17.74%2.30M
92.33%2.51M
7.64%1.76M
-33.78%2.21M
37.98%2.80M
-48.09%1.31M
-58.85%1.64M
-64.78%3.33M
-82.95%2.03M
-69.48%2.52M
-54.83%3.98M
-42.58%9.46M
69.38%11.91M
104.73%8.25M
2657.66%8.80M
6229.27%16.48M
1455.28%7.03M
407.68%4.03M
Total assets
-53.00%2.17M
33.15%7.45M
-66.12%3.18M
99.40%5.57M
-9.11%4.61M
106.69%5.60M
191.57%9.38M
-56.03%2.80M
29.61%5.07M
-53.98%2.71M
-61.17%3.22M
-20.02%6.36M
-68.36%3.91M
-64.15%5.89M
-14.69%8.29M
-13.56%7.95M
-4.69%12.37M
27.72%16.42M
-26.88%9.72M
-31.43%9.20M
Total liabilities
49.99%2.84M
106.00%4.57M
-17.83%2.30M
91.00%2.51M
14.38%1.89M
-34.00%2.22M
36.10%2.80M
-48.68%1.32M
-59.34%1.65M
-66.12%3.36M
-85.99%2.06M
-70.68%2.56M
-63.88%4.07M
-59.66%9.91M
45.62%14.71M
117.10%8.75M
1.57%11.26M
74.77%24.58M
26.00%10.10M
-51.81%4.03M
Total equity
-124.59%-669.01K
-14.65%2.88M
-86.71%874.71K
106.87%3.06M
-20.47%2.72M
618.98%3.38M
468.36%6.58M
-60.99%1.48M
2344.15%3.42M
83.84%-651.27K
118.03%1.16M
575.54%3.79M
-113.72%-152.42K
50.61%-4.03M
-1566.79%-6.42M
-115.44%-797.58K
-41.32%1.11M
-575.86%-8.16M
-107.31%-385.29K
2.28%5.17M
Net operating income
-105.04%-3.50M
-99.69%-1.53M
-82.90%-1.87M
-17.19%-2.71M
49.91%-1.71M
57.59%-764.09K
54.91%-1.02M
25.69%-2.31M
5.50%-3.41M
45.33%-1.80M
66.30%-2.26M
30.00%-3.11M
-4.94%-3.61M
12.53%-3.30M
-75.54%-6.71M
-1058.51%-4.44M
-1191.29%-3.44M
-852.45%-3.77M
-3364.87%-3.82M
-208.94%-383.29K
Net investment
----
--0.00
---123.64K
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
107.20%4.50K
----
----
-99.87%62.50K
Net financing
-105.08%-63.95K
3597.95%4.16M
-64.86%1.45M
3742.52%1.87M
-77.89%1.26M
-92.30%112.58K
4131.70%4.13M
-100.93%-51.23K
203.42%5.69M
-24.70%1.46M
-101.37%-102.45K
2177.51%5.52M
579.20%1.87M
-78.88%1.94M
181.43%7.48M
-103.25%-265.81K
-231.52%-391.27K
5556.07%9.19M
--2.66M
116.98%8.17M

FAQs

What is the total revenue of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its total revenue reached 5.07M, with a year-on-year change of 5.21M.

What are the current assets of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its current assets were 7.24M, with a year-on-year change of 35.51.

What are the total assets of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its total assets of Ensysce Biosciences Inc were 7.45M, with a year-on-year change of 33.15.

What are the total liabilities of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its total liabilities of Ensysce Biosciences Inc were 4.57M, with a year-on-year change of 106.00.

What is the total equity of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its total equity of Ensysce Biosciences Inc was 2.88M, with a year-on-year change of -14.65.

What is the net operating income of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its net operating income of Ensysce Biosciences Inc was -10.24M, with a year-on-year change of -52.17.

What is the net financing of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its net financing of Ensysce Biosciences Inc was 8.74M, with a year-on-year change of -11.57.

What is the Earnings Per Share (EPS) of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.98, with a year-on-year change of 65.24.

What is the net income of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its net income was -10.18M, with a year-on-year change of -27.40.

What is the net margin of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its net profit margin was -200.85, with a year-on-year change of -31.01.

What is the debt-to-asset ratio of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 4.12, with a year-on-year change of -23.64.

What is the Return on Equity (ROE) of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -294.00, with a year-on-year change of 37.69.

What is the Return on Assets (ROA) of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -155.96, with a year-on-year change of 18.91.

What is the operating profit of Ensysce Biosciences Inc?

According to Ensysce Biosciences Inc's FY2025 earnings report, its operating profit was -10.24M, with a year-on-year change of -52.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.